LIPOFEN is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Kowa Pharmaceuticals America Inc.. The primary component is Fenofibrate.
Product ID | 66869-137_1d1631cb-e41b-4082-aaad-4b2433dfa741 |
NDC | 66869-137 |
Product Type | Human Prescription Drug |
Proprietary Name | LIPOFEN |
Generic Name | Fenofibrate |
Dosage Form | Capsule |
Route of Administration | ORAL |
Marketing Start Date | 2007-10-01 |
Marketing Category | NDA / NDA |
Application Number | NDA021612 |
Labeler Name | Kowa Pharmaceuticals America Inc. |
Substance Name | FENOFIBRATE |
Active Ingredient Strength | 50 mg/1 |
Pharm Classes | Peroxisome Proliferator Receptor alpha Agonist [EPC] |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 2007-10-01 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA021612 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2007-10-01 |
Marketing Category | NDA |
Application Number | NDA021612 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2007-10-01 |
Ingredient | Strength |
---|---|
FENOFIBRATE | 50 mg/1 |
SPL SET ID: | 9a883573-aa2a-4376-bb0f-3b88246d2169 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |
NDC | Brand Name | Generic Name |
---|---|---|
66869-147 | LIPOFEN | LIPOFEN |
66869-137 | LIPOFEN | LIPOFEN |
0093-7755 | Fenofibrate | Fenofibrate |
0093-7756 | Fenofibrate | Fenofibrate |
0115-0511 | Fenofibrate | FENOFIBRATE |
0115-0522 | Fenofibrate | FENOFIBRATE |
0115-0533 | Fenofibrate | FENOFIBRATE |
0115-1522 | Fenofibrate | Fenofibrate |
0115-1523 | Fenofibrate | Fenofibrate |
0115-5511 | FENOFIBRATE | FENOFIBRATE |
0115-5522 | FENOFIBRATE | FENOFIBRATE |
0074-3173 | Tricor | Fenofibrate |
0074-3189 | Tricor | Fenofibrate |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
LIPOFEN 78688955 3403114 Live/Registered |
Cipher Pharmaceuticals Inc. 2005-08-09 |